Holen Sie sich die Stockscreener-App
9.16
3.51%
0.80
Schlusskurs vom Vortag:
$9.96
Offen:
$10.2
24-Stunden-Volumen:
2,306
Relative Volume:
0.17
Marktkapitalisierung:
$88.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.45M
KGV:
-0.4219
EPS:
-21.71
Netto-Cashflow:
$-31.81M
1W Leistung:
-1.22%
1M Leistung:
-6.19%
6M Leistung:
-0.67%
1J Leistung:
+0.59%
1-Tages-Spanne:
$10.19
$10.52
1-Wochen-Bereich:
$9.96
$11.56
52-Wochen-Spanne:
$5.9999
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Firmenname
Surrozen Inc
Sektor
Branche
Telefon
650-475-2820
Adresse
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Vergleichen Sie SRZN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
10.25 | 88.20M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.00 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
597.62 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
650.43 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.08 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
256.40 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-03 | Hochstufung | Guggenheim | Neutral → Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-09-15 | Eingeleitet | Guggenheim | Buy |
| 2021-09-07 | Eingeleitet | Stifel | Buy |
Surrozen Inc Aktie (SRZN) Neueste Nachrichten
Trend Tracker for (SRZN) - news.stocktradersdaily.com
Surrozen files to sell 5.21M shares of common stock for holders - MSN
When (SRZN) Moves Investors should Listen - news.stocktradersdaily.com
Finance Watch: As Stocks Tumble, Offerings Slow, Financial Alternatives Rise - insights.citeline.com
Surrozen’s Strategic Shift to Ophthalmology and Wnt Pathway Innovations Justify Buy Rating - TipRanks
Insiders Are Loving These 5 Tech and Biotech Stocks - 24/7 Wall St.
Surrozen (SRZN) to Release Earnings on Wednesday - Defense World
Surrozen Focuses on Ophthalmology Amid Financial Challenges - TipRanks
Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates - The Manila Times
Surrozen Lands Massive $175M Deal: What This Means for Its Eye Disease Pipeline - Stock Titan
Friday’s Insider Moves: Major Buys in Insurance and Biotech, Sells in Energy - Investing.com Australia
Surrozen sees $11.9 million in stock purchases by Column Group - Investing.com UK
Surrozen Secures $76.4M in Private Placement Deal - TipRanks
Surrozen drops hepatitis drug after Phase I flop - Yahoo
Surrozen shifts focus to eye disease treatments, secures $175M funding - Investing.com India
Surrozen Secures $175Mln In Oversubscribed Private Placement To Advance Ophthalmology Pipeline - Nasdaq
Surrozen to Raise Up to $175 Million in Private Placement; Fine-Tunes Ophthalmology Clinical Programs - MarketScreener
Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund - Endpoints News
Surrozen shifts focus to eye disease treatments, secures $175M funding By Investing.com - Investing.com South Africa
Surrozen, Inc. Prioritizes Ophthalmology Pipeline with $175 Million Financing and Discontinues SZN-043 Development - Nasdaq
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases - The Manila Times
Major Pivot: Surrozen Lands $175M to Develop Breakthrough Eye Disease Treatments - Stock Titan
(SRZN) Trading Advice - Stock Traders Daily
Reviewing Surrozen (NASDAQ:SRZN) & Tenaya Therapeutics (NASDAQ:TNYA) - Defense World
Wnt efforts condensing at Dewpoint, Surrozen, more - BioWorld MedTech
(SRZN) On The My Stocks Page - Stock Traders Daily
Week Ahead (Sep.13- 17): FDA Decision, Data Readouts (CALT, ASLN, LIFE…) - RTTNews
Better Warren Buffett Stock: Nu Holdings vs. Bank of America - The Globe and Mail
(SRZN) Trading Signals - Stock Traders Daily
H.C. Wainwright sets $32 target on Surrozen stock with Buy rating - MSN
How To Trade (SRZN) - Stock Traders Daily
Nektar Therapeutics (NKTR) Stock Drops Amid Biotech Sector Volat - GuruFocus.com
HC Wainwright Predicts Surrozen FY2024 Earnings - Defense World
Surrozen (NASDAQ:SRZN) Research Coverage Started at HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Surrozen (SRZN) with Buy Recommendation - MSN
This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
HC Wainwright Initiates Coverage on Surrozen With Buy Rating, $32 Price Target -January 30, 2025 at 08:15 am EST - Marketscreener.com
REGENTS OF THE UNIVERSITY OF CALIFORNIA Acquires Significant Sta - GuruFocus.com
REGENTS OF THE UNIVERSITY OF CALIFORNIA Acquires Shares in Surro - GuruFocus.com
Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation - Yahoo Finance
(SRZN) Trading Report - Stock Traders Daily
12 Health Care Stocks Moving In Thursday's Pre-Market SessionAditxt (NASDAQ:ADTX), Aclarion (NASDAQ:ACON) - Benzinga
Financial Analysis: Recursion Pharmaceuticals (NASDAQ:RXRX) versus Surrozen (NASDAQ:SRZN) - Defense World
Surrozen exec vice president sells $14,642 in stock - Investing.com
Surrozen exec vice president sells $14,642 in stock By Investing.com - Investing.com UK
Surrozen's CFO and COO sells $20,513 in stock - Investing.com
Surrozen's CFO and COO sells $20,513 in stock By Investing.com - Investing.com UK
Surrozen (NASDAQ:SRZN) Upgraded by Guggenheim to “Buy” Rating - Defense World
Surrozen stock soars to 52-week high, hits $16.35 - Investing.com
Block upgraded, Bumble downgraded: Wall Street's top analyst calls - Yahoo Finance
(SRZN) Investment Analysis and Advice - Stock Traders Daily
Finanzdaten der Surrozen Inc-Aktie (SRZN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Surrozen Inc-Aktie (SRZN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Li Yang | Exec. Vice President, Research |
Jan 03 '25 |
Sale |
17.37 |
843 |
14,643 |
13,345 |
| Williams Charles O | CFO and COO |
Jan 03 '25 |
Sale |
17.37 |
1,181 |
20,514 |
8,982 |
1.72%
0.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):